Market News AIOpen the app

Pfizer says its eczema medicine helps clear up skin a lot.

TrialRead the original at Benzinga
Good for PFE

Pfizer reported that its eczema drug improved skin clearance compared with placebo across all tested doses. The results support the drug's promise, but the ongoing Phase 2 study does not establish approval or sales.

PFE · Pfizer Inc.

AI read · Good for PFE

The AI's read

The results give Pfizer another possible treatment for eczema and show improvement across several doses. The study also found better skin and itch measures, with no dose-related safety signal. These are Phase 2 results from an ongoing study, not an approval or proof of sales, so the promise is still early.

Get alerts for PFE

Follow Pfizer Inc. (PFE) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for PFE
Free on the App Store and Google Play, or on the web.